Intelligent Bio Solutions has released a video detailing initial results from its Pharmacokinetic (PK) study, which is required for FDA 510(k) submission. The video is available on the company's website in the news and media section.The company has successfully raised approximately $250,802 (net of $7,756 in commissions) through its At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. as of November 19, 2024. The fundraising was conducted in two phases: $34,511 net through the issuance of 17,167 shares from September 18-30, and $216,291 net through 137,115 shares from October 1 to November 19, 2024.

Intelligent Bio Solutions has released a video detailing initial results from its Pharmacokinetic (PK) study, which is required for FDA 510(k) submission. The video is available on the company's website in the news and media section.The company has successfully raised approximately $250,802 (net of $7,756 in commissions) through its At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. as of November 19, 2024. The fundraising was conducted in two phases: $34,511 net through the issuance of 17,167 shares from September 18-30, and $216,291 net through 137,115 shares from October 1 to November 19, 2024.